SFC Fluidics said today that it inked a deal with JDRF to support the development of an insulin patch pump with open-protocol communication features. SFC Fluidics plans to use the two-year funding deal from JDRF to speed up the development of a patch pump that securely connects with other devices, like a continuous glucose monitor and third-party algorithms, […]
Business/Financial News
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
Spine Wave raises $5m
Spine Wave has raised $5.3 million in a new round of debt financing, according to a recently posted SEC filing. Money in the round came from 29 unnamed investors, with the first sale noted as having occurred on July 17 of this year, according to the filing. The Shelton, Conn.-based company is looking for an […]
The future of Abbott’s electrophysiology business
At DeviceTalks Minnesota 2018, medtech veteran Michael Pederson provided an inside look at the Abbott-St. Jude Medical merger and what’s ahead for Abbott’s cardiovascular technologies. Pederson tracked his career from a formative stint at HP to his current role as SVP of cardiac arrhythmias and heart failure at Abbott (NYSE:ABT). Check out his keynote address with DeviceTalks […]
Boston Scientific-backed gBeta accelerator picks 6 new startups
Minneapolis-based, Boston Scientific (NYSE:BSX) backed medtech accelerator Gener8tor announced six new entrants into its summer gBeta Medtech program last Wednesday, according to a MinneInno report. The gBeta accelerator, which is also supported by the Medical Alley Association, the University of Minnesota and the Mayo Clinic, will host the six companies in a free, seven-week long session. […]
Bayer fires back against Essure safety claims
Bayer (ETR:BAYN) last week fired back against claims that its Essure permanent birth control device is less than safe and effective after having announced plans to pull the device from the shelves in the US a week earlier. Last Thursday, the pharmaceutical giant published a press release lauding the device as the only FDA-approved non-incisional form […]
Nanobiotix inks $47m financing to support nanomedicine development
Nanobiotix (PAR:NANO.PA) inked a non-dilutive financial deal with the European Investment Bank last week to support the development of its nanoparticle-based cancer therapies. The Paris, France-based company said it landed a five-year loan to borrow up to €40 million ($46.7 million) contingent upon a set of performance milestones. Get the full story at our sister site, Drug Delivery […]
Hill-Rom shares down despite Q3 EPS, sales beat
Shares in Hill-Rom Holdings (NYSE:HRC) have fallen slightly today despite the medical device maker beating expectations on Wall Street with its fiscal year 2018 third quarter earnings results. The Chicago-based company posted profits of $45.2 million, or 67¢ per share, on sales of $708.6 million for the three months ended June 30, seeing a massive 693% […]
LeMaitre Vascular shares down on Q2 sales miss
Shares in LeMaitre Vascular (NSDQ:LMAT) have fallen slightly after the medical device maker missed sales expectations but met earnings per share consensus on Wall Street with its second quarter earnings results. The Burlington, Mass.-based company posted profits of $8.8 million, or 43¢ per share, on sales of $27 million for the three months ended June 30, […]
Abbott wins FDA nod for 14-day FreeStyle Libre glucose sensor
Abbott (NYSE:ABT) said today that the FDA approved its 14-day FreeStyle Libre flash glucose monitor, making the device the longest lasting self-applied glucose sensor on the market. The company’s FreeStyle Libre system, initially approved to last 10 days, is designed to eliminate the need for fingersticks. Users can test their blood sugar with the continuous glucose […]
Johnson & Johnson wins $227m DoD spinal implant supply contract
Johnson & Johnson (NYSE:JNJ) has won a $227.6 million maximum fixed-price contract for spinal procedure implant packages with the US Department of Defense’s Logistics Agency, according to a newly released DoD posting. The contract comes with a one-year base and an additional four single year option periods, and will position J&J to supply spinal implant devices […]
Edwards shares fall despite Q2 EPS, sales beat
Shares in Edwards Lifesciences (NYSE:EW) have fallen in early morning trading today despite the medical device maker posting second quarter earnings that topped expectations on Wall Street. The Irvine, Calif.-based company posted profits of $282.7 million, or $1.32 per share, on sales of $943.7 million for the three months ended June 30, for bottom-line growth of […]